- Cancer Biology
- Chromatography & Mass Spectrometry
- Contract Research
- Drug Discovery
- Drug Targets
- Flow Cytometry
- Informatics & Lab Automation
- Ingredients, Excipients and Dosages
- Microbiology & Rapid Micro Methods (RMMs)
- Process Analytical Technology (PAT) & Quality by Design (QbD)
- Raman Spectroscopy
- Screening, Assays & High-Content Analysis
- Thermal Processing
- Latest News
- Contact us
Pharma industry news
Posted on: 17 December 2014 | Source: Eli Lilly and Company
Eli Lilly and Company has received its third U.S. Food and Drug Administration (FDA) approval for CYRAMZA(R) (ramucirumab)...
Posted on: 17 December 2014 | Source: GlobalData
The world’s leading 30 pharmaceutical companies spent a combined $112 billion on research and development (R&D) in 2013, an increase of $723 million over the previous year, according to research and consulting firm GlobalData...
Posted on: 17 December 2014 | Source: Selvita
Selvita, Poland-based integrated drug discovery partner for the pharmaceutical and biotechnology industry, has successfully completed its Initial Public Offering...
First trial of a novel oral anticoagulant starts in prevention of recurrent stroke due to a blood clot of undetermined source
Posted on: 16 December 2014 | Source: Boehringer Ingelheim
Boehringer Ingelheim announces that the first patient has been enrolled in the RE-SPECT ESUS™ phase III study to investigate the efficacy and safety of dabigatran etexilate for the prevention of recurrent Embolic Stroke of Undetermined Source, also called ESUS...
Posted on: 16 December 2014 | Source: The Cambridge Crystallographic Data Centre
Essential resource to scientists around the world reaches historic record...
Abbott commences tender Offer and Consent Solicitation for CFR International SpA 5.125% Senior Notes due 2022
Posted on: 16 December 2014 | Source: Abbott
Abbott announced that its wholly-owned subsidiary, Abbott Laboratories (Chile) Holdco (Dos) SpA, a Chilean corporation ("ALH"), has commenced a tender offer (the "U.S. Notes Offer"), in which it is offering to purchase for cash any and all of the outstanding $300 million aggregate principal amount of 5.125% Senior Notes due 2022 (the "Notes") issued by CFR International SpA...
Posted on: 15 December 2014 | Source: Scott Sutton Ph.D. - President of Pharmaceutical Microbiology Forum & Owner of The Microbiology Network & Dr. Yongqiang Zhang - Senior Scientist at BD Diagnostics
Discussion on how a rapid method can provide a solution to a common microbiological testing problem for pharmaceutical manufacturers – process water microbiology testing.
Posted on: 15 December 2014 | Source: Orange
The U.S. Agency for International Development and global telecommunications operator Orange announced a new alliance to develop innovations in mobile health (mHealth) at the Global mHealth Forum in Washington, DC...
UK patients with moderately to severely active ulcerative colitis gain access to a range of biologic therapies on the NHS
Posted on: 15 December 2014 | Source: MSD
NICE says ‘yes’ to REMICADE® (infliximab), HUMIRA® (adalimumab) and SIMPONI® (golimumab) for adult patients with moderately to severely active ulcerative colitis...
Posted on: 15 December 2014 | Source: Abbott
Abbott announced that it has acquired control of Veropharm, a leading Russian pharmaceutical manufacturer...
Biotech-Cluster Rhine-Neckar (BioRN) leads InnoLife consortium to success in the competition Healthy Living and Active Ageing of the European Institute for Innovation and Technology (EIT)
Posted on: 15 December 2014 | Source: BioRN
Future role as German coordination centre for the largest European cooperation project in the health sector to date...
Posted on: 12 December 2014 | Source: Merck KGaA
Merck supports the World Health Organization (WHO) to fight the parasitic worm disease schistosomiasis in Africa...